Literature DB >> 7643138

Type 3 GM1 gangliosidosis: clinical and neuroradiological findings in an 11-year-old girl.

R Tanaka1, T Momoi, A Yoshida, M Okumura, S Yamakura, Y Takasaki, T Kiyomasu, C Yamanaka.   

Abstract

An 11-year-old Japanese girl was diagnosed as having type 3 GM1 gangliosidosis by clinical symptoms and enzyme assay. She was the youngest among the patients with type 3 GM1 gangliosidosis whose clinical and neuroradiological findings have been documented. Clumsiness since early infancy and dystonia since early childhood which progressed slowly without mental deterioration and dysmorphism led us to the diagnosis of type 3 GM1 gangliosidosis. Genotype determination showed point mutation in exon 2 of the beta-galactosidase gene, which is common among the patients reported in Japan. T2-weighted MRI demonstrated bilateral symmetrical hypointensity in the putamen and globus pallidus. Single photon emission computed tomography using 99mTc-HMPAO showed bilateral hyperperfusion in the basal ganglia which decreased gradually during 1 year of observation. Twenty-two patients with type 3 GM1 gangliosidosis reported in the literature whose onset was at under 15 years of age were reviewed.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7643138     DOI: 10.1007/bf00878872

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  19 in total

1.  Type 3 (adult) GM1 gangliosidosis: case report.

Authors:  K Ohta; S Tsuji; Y Mizuno; T Atsumi; T Yahagi; T Miyatake
Journal:  Neurology       Date:  1985-10       Impact factor: 9.910

2.  A case of chronic GM1 gangliosidosis presenting as dystonia: clinical and biochemical studies.

Authors:  K Inui; R Namba; Y Ihara; K Nobukuni; M Taniike; M Midorikawa; H Tsukamoto; S Okada
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

3.  Type 3 GM1 gangliosidosis: characteristic MRI findings correlated with dystonia.

Authors:  E Uyama; T Terasaki; S Watanabe; M Naito; M Owada; S Araki; M Ando
Journal:  Acta Neurol Scand       Date:  1992-12       Impact factor: 3.209

4.  Human beta-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult/chronic cases.

Authors:  K Yoshida; A Oshima; M Shimmoto; Y Fukuhara; H Sakuraba; N Yanagisawa; Y Suzuki
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

5.  Chronic GM1 gangliosidosis presenting as dystonia: I. Clinical and pathological features.

Authors:  J E Goldman; D Katz; I Rapin; D P Purpura; K Suzuki
Journal:  Ann Neurol       Date:  1981-05       Impact factor: 10.422

6.  Km defect in neuraminidase of dysmorphic type sialidosis with and without beta-galactosidase deficiency.

Authors:  Y Ben-Yoseph; T Momoi; M S Baylerian; H L Nadler
Journal:  Clin Chim Acta       Date:  1982-08-18       Impact factor: 3.786

7.  GM1-gangliosidosis (genetic beta-galactosidase deficiency): identification of four mutations in different clinical phenotypes among Japanese patients.

Authors:  J Nishimoto; E Nanba; K Inui; S Okada; K Suzuki
Journal:  Am J Hum Genet       Date:  1991-09       Impact factor: 11.025

8.  Beta-galactosidase deficiency: prolonged survival in three patients following early central nervous system deterioration.

Authors:  R E Stevenson; H A Taylor; S E Parks
Journal:  Clin Genet       Date:  1978-03       Impact factor: 4.438

9.  Parkinson plus syndrome: diagnosis using high field MR imaging of brain iron.

Authors:  B P Drayer; W Olanow; P Burger; G A Johnson; R Herfkens; S Riederer
Journal:  Radiology       Date:  1986-05       Impact factor: 11.105

10.  Adult GM1 gangliosidosis: clinical and biochemical studies on two patients and comparison to other patients called variant or adult GM1 gangliosidosis.

Authors:  D A Wenger; M Sattler; O T Mueller; G G Myers; R S Schneiman; G W Nixon
Journal:  Clin Genet       Date:  1980-05       Impact factor: 4.438

View more
  5 in total

1.  Comments on "type 3 GM1 gangliosidosis: clinical and neuroradiological findings in an 11-year-old girl".

Authors:  E Uyama; M Uchino; M Ando
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

2.  Serial MRI features of canine GM1 gangliosidosis: a possible imaging biomarker for diagnosis and progression of the disease.

Authors:  Daisuke Hasegawa; Osamu Yamato; Yuya Nakamoto; Tsuyoshi Ozawa; Akira Yabuki; Kazuhito Itamoto; Takayuki Kuwabara; Michio Fujita; Kimimasa Takahashi; Shunta Mizoguchi; Hiromitsu Orima
Journal:  ScientificWorldJournal       Date:  2012-03-12

3.  Distinct progression patterns of brain disease in infantile and juvenile gangliosidoses: Volumetric quantitative MRI study.

Authors:  Igor Nestrasil; Alia Ahmed; Josephine M Utz; Kyle Rudser; Chester B Whitley; Jeanine R Jarnes-Utz
Journal:  Mol Genet Metab       Date:  2017-12-20       Impact factor: 4.797

4.  Intracellular Delivery of β-Galactosidase Enzyme Using Arginase-Responsive Dextran Sulfate/Poly-l-arginine Capsule for Lysosomal Storage Disorder.

Authors:  Meenakshi Gupta; Himanshu Pandey; Sri Sivakumar
Journal:  ACS Omega       Date:  2017-12-15

5.  Mutations, Genes, and Phenotypes Related to Movement Disorders and Ataxias.

Authors:  Dolores Martínez-Rubio; Isabel Hinarejos; Paula Sancho; Nerea Gorría-Redondo; Raquel Bernadó-Fonz; Cristina Tello; Clara Marco-Marín; Itxaso Martí-Carrera; María Jesús Martínez-González; Ainhoa García-Ribes; Raquel Baviera-Muñoz; Isabel Sastre-Bataller; Irene Martínez-Torres; Anna Duat-Rodríguez; Patrícia Janeiro; Esther Moreno; Leticia Pías-Peleteiro; Mar O'Callaghan Gordo; Ángeles Ruiz-Gómez; Esteban Muñoz; Maria Josep Martí; Ana Sánchez-Monteagudo; Candela Fuster; Amparo Andrés-Bordería; Roser Maria Pons; Silvia Jesús-Maestre; Pablo Mir; Vincenzo Lupo; Belén Pérez-Dueñas; Alejandra Darling; Sergio Aguilera-Albesa; Carmen Espinós
Journal:  Int J Mol Sci       Date:  2022-10-06       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.